Search research articles
Contact Us
Filters
Showing results (531-540 of 741) with videos related to
Page
of 75
Sort By:
American Journal of Veterinary Research
|
April 1, 1992
Development of Anaplasma marginale in male Dermacentor andersoni transferred from parasitemic to susceptible cattle
K M Kocan, D Stiller, W L Goff, et al.
American Journal of Veterinary Research
|
January 1, 1993
Development of Anaplasma marginale in salivary glands of male Dermacentor andersoni
K M Kocan, W L Goff, D Stiller, et al.
Science Signaling
|
June 17, 2011
A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook
Annette S Little, Kathryn Balmanno, Matthew J Sale, et al.
The Clinical Neuropsychologist
|
September 14, 2007
Exploring the validity of the comprehensive trail making test
Steven R Smith, Amanda M Servesco, Jordan W Edwards, et al.
ALTEX
|
January 29, 2021
Mind the gaps: Prioritizing activities to meet regulatory needs for acute systemic lethality
Kristie Sullivan, David G Allen, Amy J Clippinger, et al.
In Vitro Cellular & Developmental Biology. Animal
|
August 27, 1998
Isolation and characterization of a novel human bladder cancer cell line: BK10
K M Roberson, D R Yancey, H Padilla-Nash, et al.
Transgenic Research
|
June 8, 2024
Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma
David W Edwards, Gabrielle M Kroepfl, Jacob M Jackson, et al.
Immunity, Inflammation and Disease
|
April 5, 2016
Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling
Direkrit Chiewchengchol, Helen L Wright, Huw B Thomas, et al.
Science Signaling
|
March 31, 2011
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells
Annette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 28, 2014
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
Knut Erik Tollefsen, Stefan Scholz, Mark T Cronin, et al.
Page
of 75
Search research articles
Search
Showing results (531-540 of 741) with videos related to
Sort By:
Page
of 75
American Journal of Veterinary Research
|
April 1, 1992
Development of Anaplasma marginale in male Dermacentor andersoni transferred from parasitemic to susceptible cattle
K M Kocan, D Stiller, W L Goff, et al.
American Journal of Veterinary Research
|
January 1, 1993
Development of Anaplasma marginale in salivary glands of male Dermacentor andersoni
K M Kocan, W L Goff, D Stiller, et al.
Science Signaling
|
June 17, 2011
A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook
Annette S Little, Kathryn Balmanno, Matthew J Sale, et al.
The Clinical Neuropsychologist
|
September 14, 2007
Exploring the validity of the comprehensive trail making test
Steven R Smith, Amanda M Servesco, Jordan W Edwards, et al.
ALTEX
|
January 29, 2021
Mind the gaps: Prioritizing activities to meet regulatory needs for acute systemic lethality
Kristie Sullivan, David G Allen, Amy J Clippinger, et al.
In Vitro Cellular & Developmental Biology. Animal
|
August 27, 1998
Isolation and characterization of a novel human bladder cancer cell line: BK10
K M Roberson, D R Yancey, H Padilla-Nash, et al.
Transgenic Research
|
June 8, 2024
Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma
David W Edwards, Gabrielle M Kroepfl, Jacob M Jackson, et al.
Immunity, Inflammation and Disease
|
April 5, 2016
Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling
Direkrit Chiewchengchol, Helen L Wright, Huw B Thomas, et al.
Science Signaling
|
March 31, 2011
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells
Annette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 28, 2014
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
Knut Erik Tollefsen, Stefan Scholz, Mark T Cronin, et al.
Page
of 75